Trial
NCT01163071
A Phase 1 Trial of ABI-011 in Patients With Advanced Solid Tumors or Lymphomas
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Celgene
Collaborators
Celgene Corporation
Condition
Advanced Solid Tumors
Intervention
ABI-011
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-11-14